John Patrick Banovetz, who serves as Executive Vice President at 3M Co (NYSE:MMM), has completed a stock transaction involving the sale of company equity. The filing, dated July 23, 2026, details the disposition of 7,880 shares of 3M common stock. Each share was sold at a price of $170.44, resulting in gross proceeds totaling approximately $1,343,067.
The sale was preceded by the exercise of 7,880 non-qualified stock options. These options allowed Mr. Banovetz to purchase the underlying shares at an exercise price of $154.69 per share, with a total exercise cost of $1,218,957. The options in question were exercisable as of February 7, 2018, and are scheduled to expire on February 6, 2027.
Following the completion of this transaction, Mr. Banovetz's direct ownership of 3M common stock stands at 50,056.816 shares. This reported holding includes shares acquired through 3M’s General Employee Stock Purchase Plan, as well as dividend share equivalents that have accrued quarterly under the company's Deferred Compensation Plan.
The executive activity comes against a backdrop of positive market performance for 3M. The stock has traded near $169.59, reflecting a 15.7% gain over the past year. According to InvestingPro analysis, the stock appears undervalued at current levels. The company has maintained dividend payments for 56 consecutive years, a detail highlighted among 8+ InvestingPro Tips available to subscribers.
3M Co. recently reported second-quarter earnings that surpassed Wall Street expectations. The company posted adjusted earnings of $2.40 per share on revenue of $6.5 billion. This performance exceeded analysts’ estimates of $2.24 per share and $6.4 billion in revenue, leading the company to raise its full-year outlook.
In response to these results, UBS raised its price target for 3M shares to $218 from $190, maintaining a Buy rating due to the company’s significant organic growth acceleration. Mizuho also adjusted its price target, increasing it to $180 from $160, citing stronger-than-expected results and an organic growth rate of 5.4%. Meanwhile, Bernstein raised its price target to $145 from $140, highlighting 3M’s strong second-quarter performance and adjusted margins of 24.9%, which were above the consensus.
These developments reflect a broader positive sentiment among analysts regarding 3M’s recent performance and future prospects. The stock currently trades at 169.78, showing a change of +0.19 (+0.11%).